Search Results - "NIELSEN, CASPER K."

Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial by Helsted, Mads M, Gasbjerg, Lærke S, Vilsbøll, Tina, Nielsen, Casper K, Forman, Julie L, Christensen, Mikkel B, Knop, Filip K

“…IntroductionDue to reports of severely reduced insulinotropic effect of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP) in type 2…”
Get full text

801-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Fatty Liver Index in Type 1 Diabetes by JOHANSEN, NICKLAS, DEJGAARD, THOMAS F., LUND, ASGER, NIELSEN, CASPER K., VILSBØLL, TINA, KNOP, FILIP K.

“…Fatty liver index (FLI), a marker of hepatic fat content, has been reported as an independent risk factor for all-cause mortality and major cardiovascular…”
Get full text

Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial by Nielsen, Casper K, Øhrstrøm, Caroline C, Kielgast, Urd L, Hansen, Dorte L, Hartmann, Bolette, Holst, Jens J, Lund, Asger, Vilsbøll, Tina, Knop, Filip K

“…To investigate the efficacy and safety of dasiglucagon, a novel stable glucagon analog in a liquid formulation, in Roux-en-Y gastric bypass (RYGB)-operated…”
Get full text

Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial by Nielsen, Casper K., Øhrstrøm, Caroline C., Houji, Inas J.K., Helsted, Mads M., Krogh, Liva S.L., Johansen, Nicklas J., Hartmann, Bolette, Holst, Jens J., Vilsbøll, Tina, Knop, Filip K.

“…OBJECTIVE Postbariatric hypoglycemia affects >50% of individuals who have undergone Roux-en-Y gastric bypass surgery. Despite the often debilitating nature of…”
Get full text

Targeting the GLP-2 receptor in the management of obesity by Pálsson, Thorir G., Gilliam-Vigh, Hannah, Jensen, Benjamin A.H., Jeppesen, Palle B., Lund, Asger B., Knop, Filip K., Nielsen, Casper K.

“…Recent advancements in understanding glucagon-like peptide 2 (GLP-2) biology and pharmacology have sparked interest in targeting the GLP-2 receptor (GLP-2R) in…”
Get full text

10-LB: Dasiglucagon Ameliorates Postprandial Hypoglycemia after Roux-en-y Gastric Bypass by NIELSEN, CASPER K., OEHRSTROEM, CAROLINE, KIELGAST, URD, HANSEN, DORTE L., LUND, ASGER, VILSBØLL, TINA, KNOP, FILIP K.

“…Introduction: Postprandial hypoglycemia is a frequent and debilitating complication following Roux-en-Y gastric bypass (RYGB) without effective treatments. In…”
Get full text